Last update 01 Nov 2024
Suzhou Shengji Pharmaceutical Co Ltd
Last update 01 Nov 2024
Overview
Tags
Urogenital Diseases
Endocrinology and Metabolic Disease
Hemic and Lymphatic Diseases
Hormone
Colony-stimulating factors
Fusion protein
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
A Phase I Clinical Trial to Compare the Pharmacokinetics, Safety and Immunogenicity of SJ04 and Ovidrel® in Healthy Female Subjects in China
比对SJ04注射液与艾泽®在中国健康女性受试者中的药代动力学、安全性和免疫原性的Ⅰ期临床试验
[Translation] Phase I clinical trial comparing the pharmacokinetics, safety and immunogenicity of SJ04 injection and Aize® in healthy Chinese female subjects
重组人卵泡刺激素-CTP融合蛋白注射液在进行辅助生殖技术（ART）患者中的II/III期临床试验
[Translation] Phase II/III clinical trial of recombinant human follicle-stimulating hormone-CTP fusion protein injection in patients undergoing assisted reproductive technology (ART)
100 Clinical Results associated with Suzhou Shengji Pharmaceutical Co Ltd
Login to view more data
Login to view more data
100 Deals associated with Suzhou Shengji Pharmaceutical Co Ltd
Login to view more data
100 Translational Medicine associated with Suzhou Shengji Pharmaceutical Co Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 28 Dec 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
2
1
Phase 3 Clinical
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free